American company Eli Lilly said it does not endorse the off-label use of Mounjaro (tirzepatide) for cosmetic weight loss. “Patient safety is Lilly’s top priority, and Lilly ne ...

Ketamine's rapid antidepressant effects have led to a significant increase in off-label psychiatric use, despite the lack of ...

In March 2023, I started working at a large retail pharmacy as a technician. Bright-eyed and bushy-tailed, I donned my crisp, blue technician’s uniform complete with my slightly lopsided name tag on ...

There's no escaping the buzz around Ozempic and Wegovy. The GLP-1 drugs continue to make headlines due to their FDA-approved uses for treating Type 2 diabetes and obesity, but a growing number of ...

The US Food and Drug Administration (FDA) held a 2-day public hearing this week to solicit input about the marketing and use of medications and medical devices for off-label use. It is fairly common ...

Off-label prescribing is when a medication is prescribed for a purpose not approved by the FDA. Insurance might cover off-label prescriptions, but it depends on the specific plan and often requires a ...

An off-label prescription drug has been shown to help some non-verbal children with autism discover the ability to speak. The drug, leucovorin, is a prescription vitamin that functions similarly to ...

The FDA has never asserted that the off-label prescribing of ivermectin for COVID-19 was prohibited; the agency has reiterated this point in court and in public filings many times prior to August 2023 ...

Developers of a cutting-edge lab-grown blood vessel designed to save life and limb in war zones and other emergency scenarios appear to be promoting its use in surgeries far beyond the product’s ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with type 1 diabetes had significant declines in ...

As common—and costly—as off-label prescribing is in oncology, it is poorly understood. It is, by nature, hard to study. Yet it is clear that the practice is changing. Skyrocketing drug costs, ...

Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...